JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2017. Vol. 62. No. 1. P. 65-69
DOI: 10.12737/25063
Evaluation of Therapeutic Gain Factor in Neutron Therapy Based on the Linear Quadratic Model
V.A. Lisin
Tomsk Cancer Research Institute, Tomsk, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
V.A. Lisin - professor, Department of applied physics, Doctor of Engineering Science
Abstract
Purpose: To study the dependencies of therapeutic gain factor (TGF) on dose of cyclotron-produced fast neutron beams using the linear-quadratic model (LQM) parameters characterizing radiation response in tumor and normal tissues.
Material and methods: The TGF in neutron therapy was calculated as the ratio of the relative biological effectiveness of neutrons for tumor (RBE tumor) to relative biological effectiveness for normal tissue (RBE normal tissue). The LQM was used to calculate the dependencies of neutron RBE on the dose and therapeutic gain factor. We considered two cases: 1) neutron therapy for 3 types of tumors with different radiation response, where the same normal tissue was critical; 2) neutron therapy for the same tumor, when 3 types of normal tissues were taken as critical.
Results: Based on calculations and analysis of published data, the dependencies of neutron RBE on dose for selected types of tumors and normal tissues were obtained. The following variants were considered: 1) RBE tumor > RBE normal tissue; 2) RBE tumor < RBE normal tissue, in both two variants, the dependencies in the therapeutic dose rate were convergent; 3) the dependencies of RBE tumor and RBE normal tissue on dose are crossed. The dependencies of TGF for neutron therapy on single boost doses and quantitative ratios between the LQM parameters characterizing radiation response of tumor and normal tissues were found. A multivariate ratio between the dependencies on dose of RBE tumor and RBE normal tissue was the cause of variety in the dependencies of TGF on dose. In the first case, the TGF increased with increasing (α/β)γ ratio and decreasing single dose, and the maximum value of TGF was equal to ~ 1.4. In the second case, TGF was < 1, i.e. the effectiveness of neutron therapy was lower than the effectiveness of gamma irradiation, but it was increased with higher single dose and lower radiosensitivity of normal tissue. In the third case, the dose at the intersection point (Di) was the boundary, and TGF was > 1 to the left of the boundary, and TPV was <1 to the right of the boundary, provided that D <Di, RBEtumor > OBEnormal tissue.
Conclusion: The obtained results with known parameters of the LQM for tumor and normal tissues allowed us to make an appropriate choice between neutron and gamma- ray therapy in order to increase the effectiveness of treatment for cancer patients. It was shown that in the case of neutron therapy, the analysis of dependencies of TGF on dose allowed the optimal dose fractionation regimen to be selected.
Key words: neutron therapy, linear-quadratic model, therapeutic gain factor
REFERENCES
- Stone R. Neutron therapy and specific ionization. Janewry Memorial Lecturell. Amer. J. Roentgenol. 1948. Vol. 59. P. 771-778.
- Catterall M., Bewley D.K. Fast Neutrons in the Treatment of Cancer. London, Academic Press, New York. Grune and Stratto. 1979. 394 p.
- Zyrjanov B.N., Musabaeva L.I., Letov V.N., Lisin V.A. Distancionnaja nejtronnaja terapija. Tomsk: Publ. TGU. 1991. 300 p. (In Russ.).
- Lisin V.A. Dozimetricheskoe komp’juternoe planirovanie terapii zlokachestvennyh opuholej puchkom bystryh nejtronov ciklotrona U-120. Med. radiol. i radiac. bezopasnost’. 1991. No. 1. P. 26-28. (In Russ.).
- Gulidov I.A., Mardynskij Ju.S., Vtjurin B.M. et al. Bystrye nejtrony reaktora v sochetannoj gamma-nejtronnoj terapii bol’nyh rakom organov polosti rta i rotoglotki. Ross. onkol. zhurnal. 2000. Vol. No. 4-7. (In Russ.).
- Gulidov I.A., Mardynskij Ju. S., Cyb A.F., Sysoev A.S. Nejtrony jadernyh reaktorov v lechenii zlokachestvennyh novoobrazovanij. Obninsk: Publ.: MRNC RAMN. 2001. 132 p. (In Russ.).
- Vazhenin A.V., Rykovanov G.N. Ural’skij centr nejtronnoj terapii: istorija sozdanija, metodologija, rezul’taty rabot. Moscow: Publ. RAMN. 2008. 124 p. (In Russ.).
- Musabaeva L.I., Zhogina Zh.A., Slonimskaja E. M., Lisin V.A. Sovremennye metody luchevoj terapii raka molochnoj zhelezy. Tomsk. 2003. 200 p. (In Russ.).
- Musabaeva L.I., Lisin V.A. Response of resistant malignant tumors to neutron therapy. Adv. Mater. Res. 2015. Vol. 1084. P. 467-470.
- Wagner F.M., Specht H., Loeper-Kabasakal B., Breitkreutz H. Sovremennoe sostoyanie terapii bystrymi nejtronami. Sib. onkol. zhurnal. 2015. No. 6. P. 5-11. (In Russ.).
- Kandakova E.YU. Kliniko-ehksperimental’noe obosnovanie povysheniya ehffektivnosti sochetannoj fotonno-nejtronnoj terapii opuholej golovy i shei. Diss. dokt. Moscow. 2015. 197 p. (In Russ.).
- Mel’nikov A.A., Vasil’ev S.A., Smol’nikova E.V. et al. Dinamika hromosomnyh aberracij i mikroyader v limfocitah bol’nyh zlokachestvennymi novoobrazovaniyami pri nejtronnoj terapii. Sib. onkol. zhurnal. 2012. No. 4. P. 52-56. (In Russ.).
- Makarova G.V. Radiobiologicheskie predposylki primeneniya bystryh nejtronov v luchevoj terapii zlokachestvennyh opuholej. V kn: «Bystrye nejtrony v luchevoj terapii zlokachestvennyh opuholej». In: Rudermana A.I., Franka I.M. (eds.). Moscow. 1976. 172 p. (In Russ.).
- Dale R.G., Jones B. The assessment of RBE effects using the concept of biologically effective dose. Int. J. Radiat. Oncol. Biol. Phys. 1999. Vol. 43. No. 3. P. 639-645.
- Osobennosti mehanizmov dejstvija plotnoionizirujushhih izluchenij. In: Savicha A.V., Mazurika V.K. (eds.) Moscow: Medicina. 1985. 230 p. (In Russ.).
- Letov V.N. Radiobiologicheskie issledovanija nejtronov. V kn: Zyrjanov B.N., Musabaeva L.I., Letov V.N., Lisin V.A. Distancionnaja nejtronnaja terapija. Tomsk: Publ. TGU. 1991. P. 48-103. (In Russ.).
- Ivanov V.I., Mashkovich V.P., Center Je.M. Mezhdunarodnaja sistema edinic v atomnoj nauke i tehnike. Moscow. Jenergoizdat. 1981. 196 p. (In Russ.).
- Lisin V.A. Ocenka parametrov linejno-kvadratichnoj modeli v nejtronnoj terapii. Med. fizika. 2010. No. 4. P. 5-12. (In Russ.).
- Carlsson J., Stenerlow B., Russell K. et al. Cell type dependent effectiveness of tumor cell inactivation by radiation with increased ionization density. Anticancer Res. 1995. Vol. 15. P. 273-282.
- Hornsey S., Field S. The RBE of cyclotron neutrons for effect on normal tissues. Eur. J. Cancer. 1974. Vol. 10. P. 231-234.
- Pavlov A.S., Fadeeva M.A., Karjakina N.F. et al. Linejno-kvadratichnaja model’ v raschetah izojeffektivnyh doz, v ocenke protivoopuholevogo jeffekta i luchevyh oslozhnenij pri luchevoj terapii zlokachestvennyh opuholej. Posobie dlja vrachej. Moscow. 2005. 67 p. (In Russ.).
For citation: Lisin VA. Evaluation of Therapeutic Gain Factor in Neutron Therapy Based on the Linear Quadratic Model. Medical Radiology and Radiation Safety. 2017;62(1):65-9. Russian. DOI: 10.12737/25063
PDF (RUS) Full-text article (in Russian)